证券记录 · 已归档季度
PGNY
Progyny, Inc. · Healthcare · Medical - Healthcare Plans
20被追踪持有人
0Δ持有人
47.53M持有股份
$1.02B报告持仓市值
+1新建仓位
−2清仓
动量输入(同类管理人): 持有人广度 0.0% · 股份流向 +3.7% · 净新建仓位 -5.0% · 公式
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 71.83K | $1.90M | n/a | n/a |
| Q2 2026 | 111 | +7 | 55.02M | $1.59B | +10 | −2 |
| Q1 2026 | 106 | -1 | 57.93M | $989.34M | +8 | −10 |
| Q4 2025 | 108 | +1 | 64.14M | $1.65B | +4 | −2 |
| Q3 2025 | 20 | 0 | 47.53M | $1.02B | +1 | −2 |
| Q2 2025 | 18 | +2 | 41.38M | $910.37M | +2 | n/a |
| Q1 2025 | 13 | +1 | 12.87M | $287.47M | +2 | −1 |
| Q4 2024 | 12 | +3 | 10.40M | $179.35M | +3 | n/a |
| Q3 2024 | 8 | -3 | 5.55M | $93.05M | +1 | −4 |
| Q2 2024 | 11 | n/a | 4.74M | $135.69M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 14.82M | +1.6% | $318.86M | 0.0% | ▲ Add | 2 | SEC ↗ ×15 |
| 2 | The Vanguard Group ✦ (被动) | 10.11M | +2.4% | $217.48M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | Fidelity (FMR) ✦ | 6.57M | +39.4% | $141.37M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 4 | State Street Global Advisors ✦ (被动) | 2.91M | +1.4% | $62.59M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.95M | +11.9% | $42.01M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | JPMorgan Chase ✦ | 1.78M | n/a | $38.25M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 7 | Goldman Sachs Group ✦ | 1.54M | n/a | $33.15M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Baillie Gifford ✦ | 1.26M | -0.8% | $27.05M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 9 | Morgan Stanley ✦ | 1.22M | n/a | $26.18M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 10 | Marshall Wace ✦ | 1.16M | -15.9% | $24.96M | 0.0% | ▼ Trim | 4 | SEC ↗ ×3 |
| 11 | Renaissance Technologies ✦ | 1.00M | +37.8% | $21.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 964.93K | -42.7% | $20.77M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 13 | Citadel Advisors ✦ | 921.90K | +181.6% | $19.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Wellington Management ✦ | 621.58K | -9.6% | $13.38M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 15 | AQR Capital Management ✦ | 254.87K | -16.0% | $5.44M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 16 | Two Sigma Investments ✦ | 167.36K | -1.4% | $3.60M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Millennium Management ✦ | 103.61K | -75.7% | $2.23M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 67.35K | +14.1% | $1.45M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 65.64K | 新增 | $1.41M | 0.0% | New | 1 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 55.23K | +6.5% | $1.19M | 0.0% | ▲ Add | 3 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| Bridgewater Associates | $1.41M | 0.0% |
已清仓
| Point72 Asset Management | $9.78M | 曾为 0.0% |
| Norges Bank | $1.70M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 283 持有人, 69.63M 股份, $1.17B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 14
Cummings Melissa B
Officer · 1.88K 股 · $52,612
Sep 23
Swartz Allison
Officer · 3.90K 股 · $101,868
Sep 10
GORDON KEVIN K
Director · 11.50K 股 · $321,358
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 06
SC 13G/A: FMR LLC
Jun 08
SC 13G/A: KLEINER PERKINS CAUFIELD & BYERS XIII…
数据来源: 持股数据来源于已解析的13F普通股持仓(被追踪范围,变动对比集);内部人行为来自Form 3/4/5;重大持股来自Schedule 13D/13G;所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据